Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Net Income (2016 - 2025)

Historic Net Income for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $15.1 million.

  • Anaptysbio's Net Income rose 14600.47% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 4891.28%. This contributed to the annual value of -$145.2 million for FY2024, which is 1123.83% up from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Net Income is $15.1 million, which was up 14600.47% from -$38.6 million recorded in Q2 2025.
  • Anaptysbio's 5-year Net Income high stood at $15.1 million for Q3 2025, and its period low was -$46.7 million during Q2 2024.
  • For the 5-year period, Anaptysbio's Net Income averaged around -$28.0 million, with its median value being -$31.4 million (2022).
  • Its Net Income has fluctuated over the past 5 years, first plummeted by 612191.14% in 2022, then skyrocketed by 14600.47% in 2025.
  • Anaptysbio's Net Income (Quarter) stood at -$31.1 million in 2021, then grew by 28.8% to -$22.1 million in 2022, then crashed by 90.71% to -$42.2 million in 2023, then surged by 48.39% to -$21.8 million in 2024, then soared by 169.38% to $15.1 million in 2025.
  • Its Net Income was $15.1 million in Q3 2025, compared to -$38.6 million in Q2 2025 and -$39.3 million in Q1 2025.